A Machine to Make a Future : : Biotech Chronicles / / Paul Rabinow, Talia Dan-Cohen.

A Machine to Make a Future represents a remarkably original look at the present and possible future of biotechnology research in the wake of the mapping of the human genome. The central tenet of Celera Diagnostics--the California biotech company whose formative work during 2003 is the focus of the b...

Full description

Saved in:
Bibliographic Details
Superior document:Title is part of eBook package: De Gruyter Princeton University Press eBook-Package Backlist 2000-2013
VerfasserIn:
Place / Publishing House:Princeton, NJ : : Princeton University Press, , [2013]
©2004
Year of Publication:2013
Edition:With a New afterword by the authors
Language:English
Online Access:
Physical Description:1 online resource (224 p.) :; 8 halftones.
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04914nam a22007455i 4500
001 9781400849666
003 DE-B1597
005 20210729020517.0
006 m|||||o||d||||||||
007 cr || ||||||||
008 210729t20132004nju fo d z eng d
019 |a (OCoLC)979746014 
020 |a 9781400849666 
024 7 |a 10.1515/9781400849666  |2 doi 
035 |a (DE-B1597)447363 
035 |a (OCoLC)880236676 
040 |a DE-B1597  |b eng  |c DE-B1597  |e rda 
041 0 |a eng 
044 |a nju  |c US-NJ 
050 4 |a QH445.2 .R336 2013 
072 7 |a SOC002000  |2 bisacsh 
082 0 4 |a 338.7  |a 338.76606  |a 338.7660609794 
100 1 |a Rabinow, Paul,   |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 2 |a A Machine to Make a Future :  |b Biotech Chronicles /  |c Paul Rabinow, Talia Dan-Cohen. 
250 |a With a New afterword by the authors 
264 1 |a Princeton, NJ :   |b Princeton University Press,   |c [2013] 
264 4 |c ©2004 
300 |a 1 online resource (224 p.) :  |b 8 halftones. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 0 |t Frontmatter --   |t Contents --   |t Overture. A MACHINE TO MAKE A FUTURE --   |t Chapter One. ENDING AND BEGINNING --   |t Chapter Two. THE STATE OF THINGS AT CELERA DIAGNOSTICS, EXPLAINED TO INVESTORS AND TO ANTHROPOLOGISTS --   |t Chapter Three. THE MACHINERY AND ITS STEWARDS --   |t Chapter Four. ETHICAL AND SOCIAL CONSULTANCY --   |t Chapter Five. CONFIDENCE AND TRUST --   |t Chapter Six. MODELS ORIENT, TECHNOLOGIES PERFORM, SAMPLES SPEAK (OR VICE VERSA) --   |t Chapter Seven. SUMMER 2003 --   |t Afterword --   |t Illustrations --   |t Appendix. A CORPORATE HISTORY --   |t Notes --   |t Glossary 
506 0 |a restricted access  |u http://purl.org/coar/access_right/c_16ec  |f online access with authorization  |2 star 
520 |a A Machine to Make a Future represents a remarkably original look at the present and possible future of biotechnology research in the wake of the mapping of the human genome. The central tenet of Celera Diagnostics--the California biotech company whose formative work during 2003 is the focus of the book--is that the emergent knowledge about the genome, with its profound implications for human health, can now be turned into a powerful diagnostic apparatus--one that will yield breakthrough diagnostic and therapeutic products (and, potentially, profit). Celera's efforts--assuming they succeed--may fundamentally reshape the fabric of how health and health care are understood, practiced, and managed. Presenting a series of interviews with all of the key players in Celera Diagnostics, Paul Rabinow and Talia Dan-Cohen open a fascinating window on the complexity of corporate scientific innovation. This marks a radical departure from other books on the biotech industry by chronicling the vicissitudes of a project during a finite time period, in the words of the actors themselves. Ultimately, the authors conclude, Celera Diagnostics is engaged in a future characterized not by geniuses and their celebrated discoveries but by a largely anonymous and widely distributed profusion of data and results--a "machine to make a future." In their new afterword, Rabinow and Dan-Cohen revisit Celera Diagnostics as its mighty machine grinds along, wondering, along with the scientists, "what constitutes success and what constitutes failure?" The pathos of the situation turns on how one poses the question as much as how one answers it. 
530 |a Issued also in print. 
538 |a Mode of access: Internet via World Wide Web. 
546 |a In English. 
588 0 |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 29. Jul 2021) 
650 0 |a Biotechnology industries  |z California. 
650 0 |a Business anthropology. 
650 7 |a SOCIAL SCIENCE / Anthropology / General.  |2 bisacsh 
700 1 |a Dan-Cohen, Talia,   |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t Princeton University Press eBook-Package Backlist 2000-2013  |z 9783110442502 
776 0 |c print  |z 9780691126142 
856 4 0 |u https://doi.org/10.1515/9781400849666 
856 4 0 |u https://www.degruyter.com/isbn/9781400849666 
856 4 2 |3 Cover  |u https://www.degruyter.com/cover/covers/9781400849666.jpg 
912 |a 978-3-11-044250-2 Princeton University Press eBook-Package Backlist 2000-2013  |c 2000  |d 2013 
912 |a EBA_BACKALL 
912 |a EBA_CL_SN 
912 |a EBA_EBACKALL 
912 |a EBA_EBKALL 
912 |a EBA_ECL_SN 
912 |a EBA_EEBKALL 
912 |a EBA_ESSHALL 
912 |a EBA_PPALL 
912 |a EBA_SSHALL 
912 |a EBA_STMALL 
912 |a GBV-deGruyter-alles 
912 |a PDA11SSHE 
912 |a PDA12STME 
912 |a PDA13ENGE 
912 |a PDA17SSHEE 
912 |a PDA5EBK